Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 12,580.70 +125.86 1.01%
S&P 500 1,332.42 +14.60 1.11%
Nasdaq 2,870.99 +33.46 1.18%
Ticker Volume Price Price Delta
STOXX 50 2,160.31 +12.39 0.58%
FTSE 100 5,391.14 +34.80 0.65%
DAX 6,396.84 +73.65 1.16%
Ticker Volume Price Price Delta
Nikkei 8,657.08 +63.93 0.74%
TOPIX 727.03 +5.92 0.82%
Hang Seng 19,055.50 +254.47 1.35%
Gold 1,556.40 -0.94%
EUR-USD 1.2499 -0.0330%
Nasdaq 2,870.99 +1.18%
DJIA 12,580.70 +1.01%
S&P 500 1,332.42 +1.11%
FTSE 100 5,391.14 +0.65%
STOXX 50 2,160.31 +0.58%
DAX 6,396.84 +1.16%
Oil (WTI) 90.88 +0.02%
U.S. 10-year 1.745% +0.007
BAC:US 7.44 +4.06%
FB:US 28.84 -9.62%
  • Exchange: NYSE MKT LLC
  • Sector: Consumer, Non-cyclical
  • Industry: Pharmaceuticals
  • Sub-Industry: Pharmacy Services

China Botanic Pharmaceutical Inc

Add to Portfolio

CBP:US

0.6000 USD 0.0400 7.14%

As of 16:16:27 ET on 05/29/2012.

Snapshot for China Botanic Pharmaceutical Inc (CBP)

Open: 0.5998 Day's Range: 0.5700 - 0.6200 Volume: 15,519 Bid: 0.5700
Previous Close: 0.5600 52wk Range: 0.4600 - 1.5100 1-Yr Rtn: -51.22% Ask: 0.6100

Stock Chart for CBP

No chart data available.
  • CBP:US 0.6000
  • 1D
  • 1M
  • 1Y
0.5600
Interactive CBP Chart

Previous Close

Key Statistics for CBP

Current P/E Ratio (ttm) 0.8219
Estimated P/E (-) -
Earnings Per Share () (ttm) 0.7300
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 22.34
Shares Outstanding (M) 37.24
Enterprise Value (M USD) (ttm) 0.92
Enterprise Value/EBITDA (ttm) 0.03
Price/Book (mrq) 0.1969
Price/Sale (ttm) 0.2856
Dividend Indicated Gross Yield 0.0000
Next Earnings Announcement 06/14/2012
More CBP Key Statistics mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Financials for CBP

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)
More CBP Income Statement Data
  • Total Assets
  • Total Liabilities (M/USD)
  • Debt to Assets (%)
More CBP Balance Sheet Data
  • Operating
  • Investing
  • Financing (M/USD)
More CBP Cash Flow Data

Company Profile & Key Executives for CBP

China Botanic Pharmaceutical Inc. researches, develops, manufactures and distributes Chinese medical products and bio-pharmaceutical products in Mainland China. The Company offers botanical anti-depression and nerve-regulation products.

Shaoming LiChairman/President/CEOWeiqiu Dong "David"Chief Financial Officer
Jiang HeSecretaryPi DianjunExecutive Manager
More Company Profile & Key Executives for CBP

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Advertisements